FOCIS 2025 Annual Meeting
FOCIS 2025 Annual Meeting
Join us in Boston for the 25th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS 2025).
FOCIS is THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.
Through the FOCIS Annual Meeting, researchers and clinicians share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those affected by immune-mediated diseases. From the introduction of monoclonal antibodies in clinical practice to recent advances in cancer immunotherapy, the past more than two decades have been transformational for patients living with immune-mediated diseases.
FOCIS 2025 will take place, in person, June 24-27, 2025, at the Boston Marriott Copley Place. Abstract submission opened on October 23, 2024. Registration and lodging details will be announced soon.
Your Health and Safety
Your health and safety remain a top priority for FOCIS. The Annual Meeting will be held fully in person, and we are committed to keeping you safe.
FOCIS 2025 Scientific Program
From the introduction of monoclonal antibodies in clinical practice — to recent advances in cancer immunotherapy – the past two decades have been transformational for patients living with immune-mediated diseases. Be part of FOCIS history and attend to learn about the latest research advances from throughout the immunology community!
FOCIS remains THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides a unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.
Through the FOCIS Annual Meeting, researchers and clinicians share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those affected with immune-mediated diseases.
FOCIS 2025 Keynote Speakers
FOCIS is pleased to announce our keynote lectures:
Program Committee
We extend a warm thank you to the committee for their time and expertise:
Joshua Milner, MD, Chair
Columbia University
Megan Cooper, MD, PhD, Co-Chair
Washington University in St. Louis
Jane L. Grogan, PhD, Past Chair
Biogen
Ignacio Anegon, MD, President
University of Nantes
Megan Sykes, MD, Past President
Columbia University
Megan Levings, PhD, President-Elect
University of British Columbia
Kavita Dhodapkar, MD, Abstract Chair
Emory University
Pam Guerrerio, MD, PhD, Abstract Co-Chair
NIAID, NIH
Galit Alter, PhD
Moderna
Shachi Bhatt, PhD, JEM Representative
Journal of Experimental Medicine
Paolo Cravedi, MD, PhD
Icahn School of Medicine at Mount Sinai
Anita Chong, PhD
University of Chicago
Leslie Kean, MD, PhD
Harvard University
Maayan Levy, PhD
University of Pennsylvania
Ciriaco Piccirillo, PhD
McGill University
Francisco Quintana, PhD
Brigham and Women’s Hospital/Harvard University
Isabelle Rivière, PhD
Takeda
Jo Viney, PhD
Seismic Therapeutic
Pamela L. Schwartzberg, MD, PhD
National Institutes of Allergy and Infectious Diseases, National Human Genome Research Institute
Dimitrios Wagner, MD, PhD
Charité – Universitätsmedizin Berlin